457.14MMarket Cap-12794P/E (TTM)
4.380High4.150Low336.89KVolume4.160Open4.120Pre Close1.46MTurnover0.35%Turnover RatioLossP/E (Static)105.09MShares5.54552wk High2.07P/B418.10MFloat Cap2.45052wk Low--Dividend TTM96.11MShs Float17.440Historical High--Div YieldTTM5.58%Amplitude2.450Historical Low4.321Avg Price1Lot Size
MaxCyte Stock Forum
NEWS
MaxCyte Signs Strategic Platform License Agreement with Legend Biotech to Accelerate Cell Therapy Discovery and Development
MaxCyte has signed a strategic platform license agreement with Legend Biotech to accelerate the discovery and development of cell therapies. Under this non-exclusive worldwide license, Legend Biotech will use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform for various cell types, including T cells and NK cells. MaxCyte will receive an...
Larger Image: tradingview.com...
$MaxCyte (MXCT.US)$
• $Antares Pharma (ATRS.US)$ +48.7% (to be acquired by Halozyme (HALO) for $5.60 per share)
• $Sierra Oncology (SRRA.US)$ +37.9% (acquired by GSK for $55 per share)
• $Amryt Pharma (AMYT.US)$ +11.7% (announces positive long-term safety and efficacy data for Mycapssa (oral octreotide) from the 2nd Year of OPTIMAL open label extension study in acromegaly patients)
• $BriaCell Therapeutics (BCTX.US)$ +6% (presents development details of...
No comment yet